Guidelines for the Management of Sexually Transmitted Infections
(2001; 88 pages)
Índice de contenido
Ver el documentoPREFACE
Abrir esta carpeta y ver su contenido1. INTRODUCTION
Cerrar esta carpeta2. TREATMENT OF STI-ASSOCIATED SYNDROMES
Abrir esta carpeta y ver su contenido2.1. Urethral discharge
Cerrar esta carpeta2.2. Genital ulcer
Ver el documentoGenital ulcer and HIV infection
Ver el documentoInguinal bubo
Ver el documento2.3. Scrotal swelling
Abrir esta carpeta y ver su contenido2.4. Vaginal discharge
Ver el documento2.5. Lower abdominal pain
Ver el documento2.6. Neonatal conjunctivitis
Abrir esta carpeta y ver su contenido3. TREATMENT OF SPECIFIC INFECTIONS
Abrir esta carpeta y ver su contenido4. KEY CONSIDERATIONS UNDERLYING TREATMENTS
Abrir esta carpeta y ver su contenido5. PRACTICAL CONSIDERATIONS IN STI CASE MANAGEMENT
Abrir esta carpeta y ver su contenido6. CHILDREN6, ADOLESCENTS AND SEXUALLY TRANSMITTED INFECTIONS
Ver el documentoANNEX. LIST OF PARTICIPANTS
 

Inguinal bubo

Inguinal and femoral buboes are localised enlargements of the lymph nodes in the groin area, which are painful and may be fluctuant. They are frequently associated with lymphogranuloma venereum and chancroid. In many cases of chancroid an associated genital ulcer is visible, but occasionally may not be. Non-sexually transmitted local and systemic infections (e.g. infections of the lower limb) can also cause swelling of inguinal lymph nodes.

Recommended syndromic treatment

• ciprofloxacin, 500mg orally, twice daily for 3 days

AND

• doxycycline, 100mg orally twice daily for 14 days

OR

• erythromycin, 500mg orally four times daily for 14 days

Some cases may require longer treatment than the 14 days recommended above. Fluctuant lymph nodes should be aspirated through healthy skin. Incision and drainage or excision of nodes may delay healing and should not be attempted.


FIGURE 4. INGUINAL BUBO

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013